1. Oridonin-induced mitochondria-dependent apoptosis in esophageal cancer cells by inhibiting PI3K/AKT/mTOR and Ras/Raf pathways
   Jin-Huan Jiang et al, 2018, J Cell Biochem CrossRef
2. Involvement of p38 Activation and Mitochondria in Death of Human Leukemia Cells Induced by an Agonistic Human Monoclonal Antibody Fab Specific to TRAIL Receptor 1
   You-Ri Lee et al, 2019, IJMS CrossRef
3. Retrochalcone Echinatin Triggers Apoptosis of Esophageal Squamous Cell Carcinoma via ROS- and ER Stress-Mediated Signaling Pathways
   Ah-Won Kwak et al, 2019, Molecules CrossRef
4. Melatonin Induces Apoptosis and Inhibits the Proliferation of Cancer Cells via Reactive Oxygen Species-mediated MAPK and mTOR Pathways
   Reena Kasi et al, 2020, CCAND CrossRef
5. Picropodophyllotoxin, an Epimer of Podophyllotoxin, Causes Apoptosis of Human Esophageal Squamous Cell Carcinoma Cells Through ROS-Mediated JNK/P38 MAPK Pathways
   Ah-Won Kwak et al, 2020, IJMS CrossRef
6. Oridonin enhances γ‑globin expression in erythroid precursors from patients with β‑thalassemia via activation of p38 MAPK signaling
   Lishan Guo et al, 2019, Mol Med Report CrossRef
7. RAGE Signaling in Melanoma Tumors
   Olamide T. Olaoba et al, 2020, IJMS CrossRef
8. Oridonin: A Review of Its Pharmacology, Pharmacokinetics and Toxicity.
   Xiang Li et al, 2021, Front Pharmacol CrossRef
9. Hypoxia and the Receptor for Advanced Glycation End Products (RAGE) Signaling in Cancer.
   Sakshi Taneja et al, 2021, Int J Mol Sci CrossRef
10. Identification of potential crucial genes and mechanisms associated with metastasis of medulloblastoma based on gene expression profile
    Guoqing Wang et al, 2022, Neurological Research CrossRef
11. Methyltransferase-like 3-induced N6-methyladenosine upregulation promotes oral squamous cell carcinoma by through p38.
    Ting Xu et al, 2021, Oral Dis CrossRef
12. Natural products targeting the MAPK-signaling pathway in cancer: overview
    Aiwen Shi et al, 2025, J Cancer Res Clin Oncol CrossRef
13. The Natural Product Oridonin as an Anticancer Agent: Current Achievements and Problems
    Xiangyan Hu et al, 2024, CPB CrossRef